Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.75
-0.14 (-2.38%)
Nov 20, 2024, 4:00 PM EST - Market open
Abeona Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Abeona Therapeutics stock have an average target of 18, with a low estimate of 15 and a high estimate of 21. The average target predicts an increase of 213.04% from the current stock price of 5.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ABEO stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +160.87% | Oct 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $18 | Buy | Reiterates | $18 | +213.04% | Oct 29, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $18 | Buy | Reiterates | $18 | +213.04% | Sep 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +160.87% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +160.87% | Jul 12, 2024 |
Financial Forecast
Revenue This Year
204.00K
from 3.50M
Decreased by -94.17%
Revenue Next Year
14.68M
from 204.00K
Increased by 7,097.06%
EPS This Year
-1.59
from -2.53
EPS Next Year
-1.51
from -1.59
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.1M | 25.8M | 114.2M | ||
| Avg | 204,000 | 14.7M | 70.7M | ||
| Low | n/a | 3.0M | 37.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -70.0% | 12,561.8% | 678.1% | ||
| Avg | -94.2% | 7,097.1% | 381.8% | ||
| Low | - | 1,392.2% | 153.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.54 | -1.17 | -0.01 | ||
| Avg | -1.59 | -1.51 | -0.73 | ||
| Low | -1.67 | -1.78 | -1.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.